Skip to main content

Featured

New Guidance Says Doctors Should Discuss Vaping as One Option to Help Adults Quit Smoking

Quitting smoking is one of the best things a person can do for their health—but it's also one of the hardest habits to break. Many smokers make several attempts before they successfully quit, even when using medications or nicotine replacement products. Now, a panel of tobacco treatment experts is encouraging healthcare providers to expand the conversation about smoking cessation by discussing nicotine e-cigarettes as one possible option for adults who smoke cigarettes. The recommendations, published in JAMA , were developed by the Harm Reduction Work Group of the Society for Research on Nicotine and Tobacco’s Treatment Research Network. Rather than promoting vaping, the group says clinicians should focus on helping patients choose the quit-smoking method that best fits their individual circumstances. A Personalized Approach to Quitting Smoking cessation isn't the same for everyone. What works well for one person may not work for another, which is why the authors recommend mo...

Analysis shows Alarming Increase in Pediatric MRSA Infections


A new study from Emory University researchers, in response to a “growing concern about the recent worldwide MRSA epidemic,” shows an “alarming” increase of pediatric MRSA infections of the head and neck.

The Emory team discovered a 16.3% increase of pediatric MRSA infections after looking at a total of 21 009 pediatric head and neck S aureus infections between January 2001 and December 31, 2006. According to Steven E. Sobol, MD, MSc, primary investigator of the study and director of Pediatric Otolaryngology in the Department of Otolaryngology - Head and Neck Surgery at Emory, "Previous studies have established that skin and soft tissue infections in some communities are due to MRSA. However, it has been observed in several institutions that there is a significant rise in pediatric head and neck infections as well."

Dr. Sobol also says, “There is a nationwide increase in the prevalence of MRSA in children with head and neck infections that is alarming. Clinicians must use antibiotic agents judiciously in order to reduce further antimicrobial drug resistance."


Between 2001 and 2006, MRSA infections from staphylococcus aureus rose from 11.8% in 2001, to 27.2% in 2004. By 2006, MRSA infections studied was 28.1%. MRSA was responsible for pediatric mouth and throat, sinus, nose, and ear infections, with the majority of cases occurring in males (51.7%).

The authors concluded, “Judicious use of antibiotic agents and increased effectiveness in diagnosis and treatment [of MRSA] are warranted to reduce further antimicrobial drug resistance in pediatric head and neck infections. Dr. Sobol suggests that clinicians keep a focus on testing for MRSA among pediatric patients, and advocates that further MRSA studies be performed to gain further insight into the MRSA superbug, now affecting increasing numbers of children.

Source:
Nationwide Trends in Pediatric Staphylococcus aureus Head and Neck Infections

Related:
New Treatment for MRSA Emerges
Experts say Development of New Antibiotics Urgently Needed
Patients develop Superbug MRSA infections after undergoing MRI Scanning

Comments

Popular Posts